About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITINGNA

EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer

NCT04141462•Centre Georges Francois Leclerc

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

CancerGenetic Predisposition

Interventions

blood sample

Locations

6

France

Locations (6)

CHRU Jean Minjoz

Besançon, France

Centre Georges-François Leclerc

Dijon, France

CHU de Dijon

Dijon, France

CHU de Reims

Reims, France

Polyclinique de Courlancy

Reims, France

CH de Troyes

Troyes, France

Key Dates

Start Date

October 7, 2019

Primary Completion Date

April 7, 2028

Completion Date

April 7, 2028

Last Updated

April 3, 2026

Related Studies

RECRUITINGPhase 2

Working Out M0 Bipolar Androgen Therapy

NCT06594926

Prostate Cancer

RECRUITINGPhase 3

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

NCT05671510

Non Small Cell Lung Cancer

RECRUITINGPhase 2

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

NCT07446322

Ras-mutated Metastatic Colorectal CancermCRC+1 more

NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors

NCT07489378

Very Rare TumorsVery Rare Cancers+3 more

Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer

NCT06713993

Esophageal Cancer (EsC)

RECRUITINGPhase 2

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

NCT06157151

Cervical CancerHPV-Related Carcinoma+3 more

View all related studies

Contacts

Sophie NAMBOT, Dr

CONTACT

03 80 29 53 13 sophie.nambot@chu-dijon.fr

Emilie REDERSTORFF

CONTACT

03 45 34 81 16 erederstorff@cgfl.fr

Sponsors

Lead Sponsor

Centre Georges Francois Leclerc

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 3, 2026Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions